FindTrial
Sign In

The independent and interaction effects of a genetic risk score and lifestyle intervention in predicting type 2 diabetes in Chinese

The independent and interaction effects of a genetic risk score and lifestyle intervention in predicting type 2 diabetes in Chinese

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-EOC-17013123
Enrollment
Unknown
Registered
2017-10-26
Start date
2017-11-01
Completion date
Unknown
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

Case series:Nil

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: individuals with normal glucose tolerance (FPG: 3.9~6.0mmol/l and 2hPG:<7.8mmol/l) and impaired glucose regulation (IGR), IGR including impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT).IFG: FPG 6.1~6.9mmol/l, 2hPG:< 7.8mmol/l, IGT:FPG < 7.0mmol/l, 2hPG 7.8~11.0mml/l.;Inclusion criteria: individuals with normal glucose tolerance (FPG: 3.9~6.0mmol/l and 2hPG:<7.8mmol/l) and impaired glucose regulation (IGR), IGR including impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT).IFG: FPG 6.1~6.9mmol/l, 2hPG:< 7.8mmol/l, IGT:FPG < 7.0mmol/l, 2hPG 7.8~11.0mml/l.;Inclusion criteria: individuals with normal glucose tolerance (FPG: 3.9~6.0mmol/l and 2hPG:<7.8mmol/l) and impaired glucose regulation (IGR), IGR including impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT).IFG: FPG 6.1~6.9mmol/l, 2hPG:< 7.8mmol/l, IGT:FPG < 7.0mmol/l, 2hPG 7.8~11.0mml/l.;Inclusion criteria: individuals with normal glucose tolerance (FPG: 3.9~6.0mmol/l and 2hPG:<7.8mmol/l) and impaired glucose regulation (IGR), IGR including impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT).IFG: FPG 6.1~6.9mmol/l, 2hPG:< 7.8mmol/l, IGT:FPG < 7.0mmol/l, 2hPG 7.8~11.0mml/l.;Inclusion criteria: individuals with normal glucose tolerance (FPG: 3.9~6.0mmol/l and 2hPG:<7.8mmol/l) and impaired glucose regulation (IGR), IGR including impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT).IFG: FPG 6.1~6.9mmol/l, 2hPG:< 7.8mmol/l, IGT:FPG < 7.0mmol/l, 2hPG 7.8~11.0mml/l.

Exclusion criteria

Exclusion criteria: individuals with diabetes;Exclusion criteria: individuals with diabetes;Exclusion criteria: individuals with diabetes;Exclusion criteria: individuals with diabetes;Exclusion criteria: individuals with diabetes

Design outcomes

Primary

MeasureTime frame
diabetes;—

Countries

China

Contacts

Public ContactJing Yan;Jing Yan;Jing Yan;Jing Yan;Jing Yan ;;;;

Shanghai Sixth People's Hospital;Shanghai Sixth People's Hospital;Shanghai Sixth People's Hospital;Shanghai Sixth People's Hospital;Shanghai Sixth People's Hospital

450550498@qq.com;450550498@qq.com;450550498@qq.com;450550498@qq.com;450550498@qq.com+86 15821069088;+86 15821069088;+86 15821069088;+86 15821069088;+86 15821069088

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026